NOBIVAC® Canine 1-DAPPv (formerly Galaxy™ DA2PPv)
Merck Animal Health
Canine Distemper-Adenovirus Type 2-Parainfluenza-Parvovirus Vaccine
MODIFIED LIVE VIRUS
For veterinary use in dogs only
IN THE ABSENCE OF A VETERINARIAN-CLIENT-PATIENT RELATIONSHIP, U.S. FEDERAL REGULATIONS PROHIBIT THE RELABELING, REPACKAGING, RESALE OR REDISTRIBUTION OF THE INDIVIDUAL CONTENTS OF THIS PACKAGE.
THIMEROSAL FREE
PRODUCT DESCRIPTION:
Nobivac® Canine 1-DAPPv vaccine is a modified live virus vaccine for the vaccination of healthy dogs as an aid in the prevention of disease caused by canine distemper virus, adenovirus type 1 (hepatitis) and adenovirus type 2 (respiratory disease), canine parainfluenza virus, and canine parvovirus. Data indicate the development of corneal opacity is not associated with the use of this product.
PRECAUTIONS:
- Store at 2° - 7°C.
- Do not freeze.
- Do not mix with other vaccines.
- Use new, non-chemically sterilized needles and syringes.
- Burn vaccine container and all unused contents.
WARNINGS:
- Contains gentamicin as a preservative.
- Vaccinate only healthy, non-parasitized dogs.
- Do not vaccinate pregnant bitches.
- The use of a biological product may produce anaphylaxis and/or other inflammatory immune-mediated hypersensitivity reactions. Antidote: Epinephrine, corticosteroids, and antihistamines may all be indicated depending on the nature and severity of the reaction.
- The age at which maternal antibody for canine parvovirus no longer interferes with the development of active immunity varies according to the bitch’s titer and quantity of colostral antibodies absorbed by the puppy.
Source: Merck Animal Health (2011) NOBIVAC® Canine 1-DAPPv (formerly Galaxy™ DA2PPv) (Internet) Available from: http://ispah.naccvp.com/index.php?m=product_view&id=1208228&key=label (accessed 09/10/2011)
_________________________________________________________________________________
NOBIVAC® Canine 1-DAPPv +Cv (formerly Galaxy™ DA2PPv+Cv)
Canine Distemper-Adenovirus Type 2-Coronavirus-Parainfluenza-Parvovirus Vaccine
MODIFIED LIVE AND KILLED VIRUS
THIMEROSAL FREE
PRODUCT DESCRIPTION:
Nobivac® Canine 1-DAPPv+Cv vaccine is a combination vaccine that unites the benefits of Nobivac® Canine 1-DAPPv and Nobivac® Canine 1-Cv in one vaccination.
Nobivac® Canine 1-DAPPv vaccine is a modified live virus vaccine for the vaccination of healthy dogs as an aid in the prevention of disease caused by canine distemper virus, adenovirus type 1 (hepatitis), adenovirus type 2 (respiratory disease), canine parainfluenza virus, and canine parvovirus. Data indicate the development of corneal opacity is not associated with the use of this product.
Nobivac® Canine 1-Cv vaccine (feline enteric coronavirus) is a killed virus vaccine for the vaccination of healthy dogs as an aid in the prevention of disease caused by canine coronavirus infection. The coronavirus has been chemically inactivated and combined with an adjuvant designed to enhance the immune response.
PRECAUTIONS:
- Store at 2° - 7°C.
- Do not freeze.
- Do not mix with other vaccines.
- Use new, non-chemically sterilized needles and syringes.
- Burn vaccine container and all unused contents.
WARNINGS:
- Contains gentamicin as a preservative.
- Vaccinate only healthy, non-parasitized dogs.
- Do not vaccinate pregnant bitches.
- The use of a biological product may produce anaphylaxis and/or other inflammatory immune-mediated hypersensitivity reactions. Antidote: Epinephrine, corticosteroids, and antihistamines may all be indicated depending on the nature and severity of the reaction.
- The age at which maternal antibody for canine parvovirus no longer interferes with the development of active immunity varies according to the bitch’s titer and quantity of colostral antibodies absorbed by the puppy.
Source: Merck Animal Health (2011) NOBIVAC® Canine 1-DAPPv +Cv (formerly Galaxy™ DA2PPv+Cv) (Internet) Available from: http://ispah.naccvp.com/index.php?m=product_view&id=1208229&key=label (accessed 09/10/2011)
______________________________________________________________________________
NOBIVAC® Canine 1-DAPPvL2 (formerly Galaxy™ DA2PPvL)
Merck Animal Health
Canine Distemper-Adenovirus Type 2-Parainfluenza-Parvovirus Vaccine
MODIFIED LIVE VIRUS
Leptospira Canicola-Icterohaemorrhagiae Bacterin
For veterinary use in dogs only
IN THE ABSENCE OF A VETERINARIAN-CLIENT-PATIENT RELATIONSHIP, U.S. FEDERAL REGULATIONS PROHIBIT THE RELABELING, REPACKAGING, RESALE OR REDISTRIBUTION OF THE INDIVIDUAL CONTENTS OF THIS PACKAGE.
PRODUCT DESCRIPTION:
Nobivac® Canine 1-DAPPvL2 vaccine is a modified live virus vaccine which is combined with an inactivated Leptospira canicola and Leptospira icterohaemorrhagiae bacterin for the vaccination of healthy dogs as an aid in the prevention of disease caused by canine distemper virus, canine adenovirus type 1 (hepatitis), canine adenovirus type 2 (respiratory disease), canine parainfluenza virus, and canine parvovirus and against Leptospiral disease due to L. canicola or L. icterohaemorrhagiae. Data indicate the development of corneal opacity is not associated with the use of this product.
PRECAUTIONS:
- Store at 2° - 7°C.
- Do not freeze.
- Do not mix with other vaccines.
- Use new, non-chemically sterilized needles and syringes.
- Burn vaccine container and all unused contents.
WARNINGS:
- Contains gentamicin and thimerosal as preservatives.
- Vaccinate only healthy, non-parasitized dogs.
- Do not vaccinate pregnant bitches.
- The use of a biological product may produce anaphylaxis and/or other inflammatory immune-mediated hypersensitivity reactions. Antidote: Epinephrine, corticosteroids, and antihistamines may all be indicated depending on the nature and severity of the reaction.
- The age at which maternal antibody for canine parvovirus no longer interferes with the development of active immunity varies according to the bitch’s titer and quantity of colostral antibodies absorbed by the puppy.
Source: Merck Animal Health (2011) NOBIVAC® Canine 1-DAPPvL2 (formerly Galaxy™ DA2PPvL) (Internet) Available from: http://ispah.naccvp.com/index.php?m=product_view&id=1208230&key=label (accessed 09/10/2011)
______________________________________________________________________________
Canine Distemper-Adenovirus Type 2-Coronavirus-Parainfluenza-Parvovirus Vaccine
MODIFIED LIVE & KILLED VIRUS
Leptospira Canicola-Icterohaemorrhagiae Bacterin
For veterinary use in dogs only
IN THE ABSENCE OF A VETERINARIAN-CLIENT-PATIENT RELATIONSHIP, U.S. FEDERAL REGULATIONS PROHIBIT THE RELABELING, REPACKAGING, RESALE OR REDISTRIBUTION OF THE INDIVIDUAL CONTENTS OF THIS PACKAGE.
PRODUCT DESCRIPTION:
Nobivac® Canine 1-DAPPvL2+Cv vaccine is a combination vaccine that unites the benefits of Nobivac® Canine 1-DAPPvL2 and Nobivac® Canine 1-Cv in one vaccination.
Nobivac® Canine 1-DAPPvL2 vaccine is a modified live virus vaccine which is combined with an inactivated Leptospira canicola and Leptospira icterohaemorrhagiae bacterin for the vaccination of healthy dogs as an aid in the prevention of disease caused by canine distemper virus, canine adenovirus type 1 (hepatitis), canine adenovirus type 2 (respiratory disease), canine parainfluenza virus, and canine parvovirus and against Leptospiral disease due to L. canicola or L. icterohaemorrhagiae. Data indicate the development of corneal opacity is not associated with the use of this product.
Nobivac® Canine 1-Cv vaccine (feline enteric coronavirus) is a killed virus vaccine for the vaccination of healthy dogs as an aid in the prevention of disease caused by canine coronavirus infection. The coronavirus has been chemically inactivated and combined with an adjuvant designed to enhance the immune response.PRECAUTIONS:
- Store at 2° - 7°C.
- Do not freeze.
- Do not mix with other vaccines.
- Use new, non-chemically sterilized needles and syringes.
- Burn vaccine container and all unused contents.
WARNINGS:
- Contains gentamicin and thimerosal as preservatives.
- Vaccinate only healthy, non-parasitized dogs.
- Do not vaccinate pregnant bitches.
- The use of a biological product may produce anaphylaxis and/or other inflammatory immune-mediated hypersensitivity reactions. Antidote: Epinephrine, corticosteroids, and antihistamines may all be indicated depending on the nature and severity of the reaction.
- The age at which maternal antibody for canine parvovirus no longer interferes with the development of active immunity varies according to the bitch’s titer and quantity of colostral antibodies absorbed by the puppy
Source: Merck Animal Health (2011) NOBIVAC® Canine 1-DAPPvL2+Cv (formerly Galaxy™ DA2PPvL+Cv) (Internet) Available from: http://ispah.naccvp.com/index.php?m=product_view&id=1208231&key=label (accessed 09/10/2011)
________________________________________________________________________________
NOBIVAC® Puppy-DPv (formerly PROGARD®-PUPPY DPv)Merck Animal HealthCanine Distemper-Parvovirus Vaccine
MODIFIED LIVE VIRUS
For veterinary use in dogs only
IN THE ABSENCE OF A VETERINARIAN-CLIENT-PATIENT RELATIONSHIP, U.S. FEDERAL REGULATIONS PROHIBIT THE RELABELING, REPACKAGING, RESALE OR REDISTRIBUTION OF THE INDIVIDUAL CONTENTS OF THIS PACKAGE.
THIMEROSAL FREE
PRODUCT DESCRIPTION:
Nobivac® Puppy-DPv is a modified live virus vaccine containing attenuated strains of canine distemper virus (CDV) and parvovirus (CPV). This vaccine is for vaccination of healthy dogs as an aid in the prevention of disease caused by canine distemper virus and canine parvovirus.PRECAUTIONS:
- Store at 2° - 7°C (35°-45°F).
- Do not freeze.
- Shake well before use.
- Use contents promptly once reconstituted.
- Use new, non-chemically sterilized needles and syringes.
- Burn vaccine container and all unused contents.
- Contains gentamicin and amphotericin B as preservatives.
- Vaccinate only healthy, non-parasitized dogs.
- Do not vaccinate pregnant bitches.
- The use of a biological product may produce anaphylaxis and/or other inflammatory immune-mediated hypersensitivity reactions. Antidote: Epinephrine, corticosteroids, and antihistamines may all be indicated depending on the nature and severity of the reaction.
Source: Merck Animal Health (2011) NOBIVAC® Puppy-DPv (formerly PROGARD®-PUPPY DPv) (Internet) Available from: http://ispah.naccvp.com/index.php?m=product_view&id=1208246&key=label (accessed 09/10/2011)_________________________________________________________________________________
NOBIVAC® LYME
Merck Animal Health
Borrelia Burgdorferi Bacterin
For veterinary use in dogs only
IN THE ABSENCE OF A VETERINARIAN-CLIENT-PATIENT RELATIONSHIP, U.S. FEDERAL REGULATIONS PROHIBIT THE RELABELING, REPACKAGING, RESALE, OR REDISTRIBUTION OF THE INDIVIDUAL CONTENTS OF THIS PACKAGE.
PRODUCT DESCRIPTION:
Nobivac® Lyme bacterin contains two inactivated isolates of Borrelia burgdorferi. This bacterin is for the vaccination of healthy dogs as an aid in the prevention of subclinical arthritis caused by Borrelia burgdorferi.
PRECAUTIONS:
- Store at 2° - 7°C.
- Do not freeze.
- Do not mix with other vaccines.
- Use new, non-chemically sterilized needles and syringes.
WARNINGS:
- Contains gentamicin and amphotericin B as preservatives.
- Transient soft tissue swelling may occur at the injection site.
- The use of this biological product may produce anaphylaxis and/or other inflammatory immune-mediated hypersensitivity reactions. Antidote: Epinephrine, corticosteroids, and antihistamines may all be indicated depending on the nature and severity of the reaction.
Source: Merck Animal Health (2011) NOBIVAC® LYME (Internet) Available from: http://ispah.naccvp.com/index.php?m=product_view&id=1208044&key=label (accessed 09/10/2011)
_________________________________________________________________________________
NOBIVAC® Canine Flu H3N8Merck Animal Health
Canine Influenza Vaccine
H3N8, KILLED VIRUS
For veterinary use in dogs only
IN THE ABSENCE OF A VETERINARIAN-CLIENT-PATIENT RELATIONSHIP, U.S. FEDERAL REGULATIONS PROHIBIT THE RELABELING, REPACKAGING, RESALE OR REDISTRIBUTION OF THE INDIVIDUAL CONTENTS OF THIS PACKAGE.
THIMEROSAL FREE
PRODUCT DESCRIPTION:
Nobivac® Canine Flu H3N8 is recommended for the vaccination of healthy dogs at 6 weeks of age or older as an aid in the control of disease associated with canine influenza virus infection. The type A, subtype H3N8 virus has been chemically inactivated and combined with an adjuvant designed to enhance the immune response. The vaccine has been demonstrated to reduce the incidence and severity of lung lesions, as well as the duration of coughing and viral shedding.
PRECAUTIONS:
- Store at 2° - 7°C.
- Do not freeze.
- Do not mix with other vaccines.
- Vaccinate only healthy, non-parasitized dogs.
- Use new, non-chemically sterilized needles and syringes.
WARNINGS:
- Contains gentamicin and amphotericin B as preservatives.
- Do not vaccinate pregnant bitches.
- The use of a biological product may produce anaphylaxis and/or other inflammatory immune-mediated hypersensitivity reactions. Antidote: Epinephrine, corticosteroids, and antihistamines may all be indicated depending on the nature and severity of the reaction.Source: Merck Animal Health (2011) NOBIVAC® Canine Flu H3N8 (Internet) Available from: http://ispah.naccvp.com/index.php?m=product_view&id=1208226&key=label (accessed 09/10/2011)